The effects of progesterone on the alpha2-adrenergic receptor subtypes in late-pregnant uterine contractions in vitro. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Hajagos-Tóth, Judit; Bóta, Judit; Ducza, Eszter; Samavati, Reza; Borsodi, Anna; Benyhe, Sándor; Gáspár, Róbert
• Is Part Of: Reproductive biology and endocrinology. Volume 14:Issue 1(2016)
• Page Start: 1
• Page End: 9
• Publication Date: 2016-12
• Subjects: Progesterone -- Gestation -- Rat -- Myometrium -- α2-adrenergic receptor subtypes; Reproduction -- Periodicals; Generative organs -- Pathophysiology -- Periodicals; Reproduction -- Endocrine aspects -- Periodicals; Endocrine glands -- Diseases -- Periodicals; Embryology -- Periodicals; 571.8
• DOI: 10.1186/s12958-016-0166-9
• Languages: English
• ISSNs: 1477-7827

Abstract

Abstract Background The adrenergic system and progesterone play major roles in the control of the uterine function. Our aims were to clarify the changes in function and expression of the α2 -adrenergic receptor (AR) subtypes after progesterone pretreatment in late pregnancy. Methods Sprague Dawley rats from pregnancy day 15 were treated with progesterone for 7 days. The myometrial expressions of the α2 -AR subtypes were determined by RT-PCR and Western blot analysis. In vitro contractions were stimulated with (−)-noradrenaline, and its effect was modified with the selective antagonists BRL 44408 (α2A ), ARC 239 (α2B/C ) and spiroxatrine (α2A ). The accumulation of myometrial cAMP was also measured. The activated G-protein level was investigated via GTPγS binding assays. Results Progesterone pretreatment decreased the contractile effect of (−)-noradrenaline through the α2 -ARs. The most significant reduction was found through the α2B -ARs. The mRNA of all of the α2 -AR subtypes was increased. Progesterone pretreatment increased the myometrial cAMP level in the presence of BRL 44408 (p < 0.001), spiroxatrine (p < 0.001) or the spiroxatrine + BRL 44408 combination (p < 0.05). Progesterone pretreatment increased the G-protein-activating effect of (−)-noradrenaline in the presence of the spiroxatrine + BRL 44408 combination. Conclusions The expression of the α2 -AR subtypes is progesterone-sensitive. It decreases the contractile response of (−)-noradrenaline through the α2B -AR subtype, blocks the function of α2A -AR subtype and alters the G protein coupling of these receptors, promoting a Gs -dependent pathway. A combination of α2C -AR agonists and α2B -AR antagonists with progesterone could be considered for the treatment or prevention of preterm birth.